Evasion of the Antiviral Innate Immunity by PRV.

Autor: Wang C; College of Life Sciences, Henan Agricultural University, Zhengzhou 450046, China., Li L; College of Life Sciences, Henan Agricultural University, Zhengzhou 450046, China., Zhai X; College of Life Sciences, Henan Agricultural University, Zhengzhou 450046, China., Chang H; College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China., Liu H; College of Life Sciences, Henan Agricultural University, Zhengzhou 450046, China.
Jazyk: angličtina
Zdroj: International journal of molecular sciences [Int J Mol Sci] 2024 Dec 06; Vol. 25 (23). Date of Electronic Publication: 2024 Dec 06.
DOI: 10.3390/ijms252313140
Abstrakt: Pseudorabies virus (PRV) establishes persistent latent infections by effectively evading the host's antiviral innate immune response. PRV has developed sophisticated strategies to bypass immune surveillance through coevolution with its host. Currently, no effective vaccine exists to prevent or treat infections caused by emerging PRV variants, and the interactions between PRV and the host's innate immune defenses remain incompletely understood. Nevertheless, ongoing research is uncovering insights that may lead to novel treatments and preventive approaches for herpesvirus-related diseases. This review summarizes recent advances in understanding how PRV disrupts key adaptors in immune signaling pathways to evade antiviral immunity. Additionally, we explored the intrinsic cellular defenses that play crucial roles in combating viral invasion. A deeper understanding of the immune evasion strategies of PRV could inform the development of new therapeutic targets and vaccines.
Competing Interests: The authors declare no conflicts of interest.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje